Sexual health and quality of life after cervical cancer treatment
Tests a sexual health and lifestyle program in adults treated for cervical cancer.
Plain-language title generated from the registry record
Registry title: Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer
Key facts
- Where
- Teià, SpainSee the site
- Phase
- Phase 4
Where in Spain
- Laura BurunatTeià, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundacion Clinic per a la Recerca Biomédica
- Trial code
- NCT07412873
- Record updated
- 17 February 2026
- Original description
To assess the improvement in sexual function and self-perceived quality of life using PROMs (Patient-Reported Outcomes) in patients treated for cervical cancer who undergo a multimodal intervention in the sexual sphere and lifestyle compared to those who undergo care within routine clinical practice.Read full original descriptionShow less
Prospective Randomized Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer
To assess the improvement in sexual function and self-perceived quality of life using PROMs (Patient-Reported Outcomes) in patients treated for cervical cancer who undergo a multimodal intervention in the sexual sphere and lifestyle compared to those who undergo care within routine clinical practice.
Inclusion: Women of legal age; Patients with primary cervical cancer stage FIGO I-III (initial or locally advanced) of squamous histology, adenocarcinoma or adenosquamous; Patients treated for cancer with surgery and/or radiotherapy ± systemic treatment in the Gynaecological Oncology Units of hospitals in Spain; Complete response after oncospecific treatment was obtained; Signature of the informed consent (IC) by the patient or responsible family member.
Exclusion: Patients under 18 years of age; Pregnancy or breastfeeding; Partial response after completion of oncospecific treatment; Patients with premalignant pathology; Diagnosis of a tumor of non-cervical origin or atypical histologies; Impossibility of completing the questionnaires included in the protocol autonomously; Contraindications to the use of vaginal estrogens; Patients undergoing fertility-sparing treatment (trachelectomy or conization); Patients undergoing palliative treatment.